BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31529618)

  • 1. Anti-retroviral therapy scale-up and its impact on sex-stratified tuberculosis notification trends in Uganda.
    Zawedde-Muyanja S; Manabe YC; Musaazi J; Mugabe FR; Ross JM; Hermans S
    J Int AIDS Soc; 2019 Sep; 22(9):e25394. PubMed ID: 31529618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis.
    Hermans S; Boulle A; Caldwell J; Pienaar D; Wood R
    J Int AIDS Soc; 2015; 18(1):20240. PubMed ID: 26411694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential impact of HIV and antiretroviral therapy on gender-specific tuberculosis rates.
    Hermans S; Cornell M; Middelkoop K; Wood R
    Trop Med Int Health; 2019 Apr; 24(4):454-462. PubMed ID: 30681241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
    Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
    J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
    Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
    BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.
    Saito S; Mpofu P; Carter EJ; Diero L; Wools-Kaloustian KK; Yiannoutsos CT; Beverly MS; Tsiouris S; Somi GR; Ssali J; Nash D; Elul B
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):e96-e106. PubMed ID: 26910387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community.
    Middelkoop K; Bekker LG; Myer L; Johnson LF; Kloos M; Morrow C; Wood R
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):263-9. PubMed ID: 21317585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda.
    Hermans SM; Castelnuovo B; Katabira C; Mbidde P; Lange JM; Hoepelman AI; Coutinho A; Manabe YC
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e29-35. PubMed ID: 22395671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda.
    Musaazi J; Sekaggya-Wiltshire C; Kiragga AN; Kalule I; Reynolds SJ; Manabe YC; Castelnuovo B
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):514-521. PubMed ID: 31064632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
    Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy.
    Suwanpimolkul G; Gatechompol S; Kawkitinarong K; Ueaphongsukkit T; Sophonphan J; Siriyakorn N; Jirajariyavej S; Khusuwan S; Panarat P; Wannalerdsakun S; Saetiew N; Chayangsu S; Wiwatrojanagul S; Noopetch P; Danpornprasert P; Mekviwattanawong S; Fujitnirun C; Lertpiriyasuwat C; Han WM; Kerr SJ; Ruxrungtham K; Avihingsanon A;
    J Int AIDS Soc; 2022 Apr; 25(4):e25900. PubMed ID: 35384317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi.
    Zachariah R; Bemelmans M; Akesson A; Gomani P; Phiri K; Isake B; van den Akker T; Philips M; Mwale A; Gausi F; Kwanjana J; Harries AD
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):933-7. PubMed ID: 21682967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.
    Auld AF; Mbofana F; Shiraishi RW; Alfredo C; Sanchez M; Ellerbrock TV; Nelson LJ
    PLoS One; 2013; 8(1):e54665. PubMed ID: 23349948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?
    Lawn SD; Harries AD; Williams BG; Chaisson RE; Losina E; De Cock KM; Wood R
    Int J Tuberc Lung Dis; 2011 May; 15(5):571-81. PubMed ID: 21756508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.
    Koenig SP; Bernard D; Dévieux JG; Atwood S; McNairy ML; Severe P; Marcelin A; Julma P; Apollon A; Pape JW
    PLoS One; 2016; 11(2):e0146903. PubMed ID: 26901795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
    Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
    HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.
    Hermans SM; van Leth F; Kiragga AN; Hoepelman AI; Lange JM; Manabe YC
    Trop Med Int Health; 2012 Dec; 17(12):1527-33. PubMed ID: 23130871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).
    Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
    Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
    BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.